Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cell Source Inc (CLCS)
OTHER OTC:CLCS
Cell Source (CLCS) Stock Price & Analysis
6 Followers
CLCS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $0.74
Previous Close$0.4
Volume1.00K
Average Volume (3M)11.11K
Market Cap
$7.71K
Enterprise Value$135.17K
Total Cash (Recent Filing)$2.58K
Total Debt (Recent Filing)$130.04K
Price to Earnings (P/E)-2.2
Beta206.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding38,546,231
10 Day Avg. Volume1,581
30 Day Avg. Volume11,105
Standard Deviation35.93
R-Squared0.05
Alpha8.28
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
15.11%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
84.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CLCS FAQ
What was Cell Source Inc’s price range in the past 12 months?
Cell Source Inc lowest stock price was $0.20 and its highest was $0.74 in the past 12 months.
What is Cell Source Inc’s market cap?
Currently, no data Available
When is Cell Source Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cell Source Inc’s earnings last quarter?
Currently, no data Available
Is Cell Source Inc overvalued?
According to Wall Street analysts Cell Source Inc’s price is currently Overvalued.
Does Cell Source Inc pay dividends?
Cell Source Inc does not currently pay dividends.
What is Cell Source Inc’s EPS estimate?
Cell Source Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cell Source Inc have?
Cell Source Inc has 38,546,230 shares outstanding.
What happened to Cell Source Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cell Source Inc?
Currently, no hedge funds are holding shares in CLCS
---
Company Description
Cell Source Inc
Cell Source, Inc. is a biotechnology company, which engages in the development of cell therapy treatments based on the management of immune tolerance. The firm's lead product, Veto-Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company was founded on June 6, 2012 and is headquartered in New York, NY.
---
Technical Analysis
---